Skip to main content
Equibles

CAZ INVESTMENTS LP

Position in CYDY — CytoDyn Inc.

CIK 1159363 HOUSTON, TX
Back to CYDY Full portfolio

Position in CYDY

as of Jun 30, 2026 · filed Aug 24, 2026
Position Value
$960
-$120 QoQ
Shares Held
4,000
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 6 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CYDY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CAZ INVESTMENTS LP holds $67,625 across 3 Biotechnology names. CYDY ranks #3 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DSGN
Design Therapeutics, Inc.
 3,500 $50,645
2 SPRY
ARS Pharmaceuticals, Inc.
 2,000 $16,020
3 CYDY
CytoDyn Inc.
This page 		4,000 $960

All Filings in CYDY

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $960 4,000
2026-03-31 $1,080 4,000
2025-12-31 $1,120 4,000
2025-09-30 $1,040 4,000
2025-06-30 $1,080 4,000
2025-03-31 $920 4,000
2024-12-31 $440 4,000
2024-09-30 $1 4,000
2024-06-30 $1 4,000
2024-03-31 $1 4,000
2023-12-31 $1 4,000
2023-09-30 $1 4,000
2023-06-30 $1,080 4,000
2023-03-31 $1 4,000
2022-12-31 $920 4,000
2022-09-30 $1,680 4,000
2022-06-30 $1,680 4,000
2022-03-31 $1,480 4,000
2021-12-31 $3,960 4,000
2021-09-30 $7,920 4,000
2021-06-30 $6,800 4,000
2021-03-31 $10,800 4,000
2020-12-31 $21,560 4,000
2020-09-30 $11,680 4,000
2020-06-30 $22,720 4,000